• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Editorial Comment from Dr Hatakeyama and Dr Ohyama to Clinical utility of head computed tomography scan during systemic therapy for metastatic renal cell carcinoma.

作者信息

Hatakeyama Shingo, Ohyama Chikara

机构信息

Department of Advanced Blood Purification Therapy, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan.

Department of Urology, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan.

出版信息

Int J Urol. 2021 Apr;28(4):456-457. doi: 10.1111/iju.14508. Epub 2021 Feb 1.

DOI:10.1111/iju.14508
PMID:33525053
Abstract
摘要

相似文献

1
Editorial Comment from Dr Hatakeyama and Dr Ohyama to Clinical utility of head computed tomography scan during systemic therapy for metastatic renal cell carcinoma.
Int J Urol. 2021 Apr;28(4):456-457. doi: 10.1111/iju.14508. Epub 2021 Feb 1.
2
Editorial Comment from Dr Kondo to Clinical utility of head computed tomography scan during systemic therapy for metastatic renal cell carcinoma.
Int J Urol. 2021 Apr;28(4):457-458. doi: 10.1111/iju.14520. Epub 2021 Feb 10.
3
Computed tomography characteristics of unresectable primary renal cell carcinoma treated with neoadjuvant sunitinib.新辅助舒尼替尼治疗不可切除的原发性肾细胞癌的计算机断层扫描特征。
Clin Genitourin Cancer. 2014 Apr;12(2):117-23. doi: 10.1016/j.clgc.2013.08.001. Epub 2013 Oct 12.
4
Editorial comment from Dr Yuasa to efficacy of traditional and alternative sunitinib treatment schedules in Japanese patients with metastatic renal cell carcinoma.汤浅博士对日本转移性肾细胞癌患者传统及替代舒尼替尼治疗方案疗效的编辑评论。
Int J Urol. 2014 Oct;21(10):1069-70. doi: 10.1111/iju.12536. Epub 2014 Jun 26.
5
Editorial comment from Dr Yokomizo to efficacy of traditional and alternative sunitinib treatment schedules in Japanese patients with metastatic renal cell carcinoma.横见博士对日本转移性肾细胞癌患者传统及替代舒尼替尼治疗方案疗效的编辑评论。
Int J Urol. 2014 Oct;21(10):1069. doi: 10.1111/iju.12528. Epub 2014 Jun 16.
6
Clinical utility of head computed tomography scan during systemic therapy for metastatic renal cell carcinoma.头部计算机断层扫描在转移性肾细胞癌全身治疗中的临床应用价值
Int J Urol. 2021 Apr;28(4):450-456. doi: 10.1111/iju.14490. Epub 2021 Feb 1.
7
The prognostic and predictive value of vascular response parameters measured by dynamic contrast-enhanced-CT, -MRI and -US in patients with metastatic renal cell carcinoma receiving sunitinib.动态对比增强 CT、MRI 和 US 测量的血管反应参数在接受舒尼替尼治疗的转移性肾细胞癌患者中的预后和预测价值。
Eur Radiol. 2018 Jun;28(6):2281-2290. doi: 10.1007/s00330-017-5220-2. Epub 2018 Jan 30.
8
Optimizing the size variation threshold for the CT evaluation of response in metastatic renal cell carcinoma treated with sunitinib.优化 CT 评估转移性肾细胞癌患者舒尼替尼治疗反应的大小变化阈值。
Ann Oncol. 2010 May;21(5):936-41. doi: 10.1093/annonc/mdp466. Epub 2009 Nov 4.
9
Editorial comment.编者按。
Urology. 2010 May;75(5):1114-5; author reply 1115. doi: 10.1016/j.urology.2009.07.1291.
10
Editorial comment.编者按
Urology. 2010 May;75(5):1114; author reply 1115. doi: 10.1016/j.urology.2009.07.1290.